News

India], May 8: Merck Foundation, the philanthropic arm of Merck KGaA Germany underscored their long-term commitment to build ...
In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...